» Articles » PMID: 23666114

Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers

Overview
Journal J Genet Couns
Publisher Wiley
Specialty Genetics
Date 2013 May 14
PMID 23666114
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies examining communication of BRCA1/2 results with relatives and family uptake of BRCA1/2 testing have sampled from predominantly white, high SES cohorts ascertained solely from tertiary care centers. No studies have focused on family communication and testing among relatives of diverse BRCA1/2 carriers. We conducted structured interviews with 73 BRCA1/2 carriers identified at a public hospital and a tertiary cancer center. We asked participants if each first- and second-degree relative was aware of their BRCA1/2 results and whether or not each relative had tested. Generalized estimating equations identified rates and predictors of family communication and testing. Participants disclosed their test results to 73 % of 606 eligible relatives and 31 % of 514 eligible relatives tested. Communication and testing rates were similar for relatives of participants from the public hospital and the tertiary cancer center. Hospital site was not a significant predictor of either result disclosure or relative uptake of testing. African American and Asian/Pacific Islander participants were significantly less likely to disclose their results to their relatives; relatives of African American participants were significantly less likely to test. Addressing these disparities will require further research into the best ways to facilitate family communication and counsel at-risk relatives of racially and socioeconomically diverse BRCA1/2 mutation carriers.

Citing Articles

Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical Management.

Osler T, Schoeman M, Edge J, Pretorius W, Rabe F, Mathew C Cancer Med. 2025; 14(5):e70743.

PMID: 40042150 PMC: 11881015. DOI: 10.1002/cam4.70743.


Cascade genetic testing in hereditary cancer: exploring the boundaries of the Italian legal framework.

Varesco L, Di Tano F, Monducci J, Sciallero S, Turchetti D, Bighin C Fam Cancer. 2024; 24(1):9.

PMID: 39565467 DOI: 10.1007/s10689-024-00430-y.


Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome.

Peipins L, Dasari S, Viox M, Rodriguez J Breast Cancer Res Treat. 2024; 208(1):19-27.

PMID: 39046629 DOI: 10.1007/s10549-024-07377-9.


The relationship between demographic factors and known risk factors with breast cancer in women aged 30-69.

Jahani M, Ghasemi B, Soltani S, Naderi M, Nikbakht H, Hashemi S Ann Med Surg (Lond). 2024; 86(7):3945-3953.

PMID: 38989175 PMC: 11230782. DOI: 10.1097/MS9.0000000000002114.


Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients.

Hodan R, Picus M, Stanclift C, Ormond K, Pichardo J, Kurian A J Community Genet. 2024; 15(4):363-374.

PMID: 38814439 PMC: 11410745. DOI: 10.1007/s12687-024-00712-z.


References
1.
Kurian A, Gong G, Chun N, Mills M, Staton A, Kingham K . Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol. 2008; 26(29):4752-8. PMC: 2653135. DOI: 10.1200/JCO.2008.16.8310. View

2.
Haffty B, Choi D, Goyal S, Silber A, Ranieri K, Matloff E . Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Ann Oncol. 2009; 20(10):1653-9. DOI: 10.1093/annonc/mdp051. View

3.
Plon S, Cooper H, Parks B, Dhar S, Kelly P, Weinberg A . Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genet Med. 2011; 13(2):148-54. PMC: 3096073. DOI: 10.1097/GIM.0b013e318207f564. View

4.
Kauff N, Mitra N, Robson M, Hurley K, Chuai S, Goldfrank D . Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. J Natl Cancer Inst. 2005; 97(18):1382-4. DOI: 10.1093/jnci/dji281. View

5.
Narod S . Screening for BRCA1 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective. Salud Publica Mex. 2009; 51 Suppl 2:s191-6. DOI: 10.1590/s0036-36342009000800009. View